cancer treatment drug: Dr Reddy’s Laboratories launches cancer treatment drug Capecitabine in US


New Delhi: Drug main Dr Reddy’s Laboratories on Wednesday stated it has launched cancer treatment drug Capecitabine tablets in the US market.

The product is a therapeutic equal generic model of Xeloda (capecitabine) tablets permitted by the US Food and Drug Administration (USFDA).

In a regulatory submitting, Dr Reddy’s laboratories introduced launch of Capecitabine tablets in the US.

Quoting IQVIA Health knowledge, Dr Reddy’s stated the Xeloda model and generic had US gross sales of roughly USD 90 million for the newest 12 months ending in October 2020.

Dr Reddy’s Capecitabine Tablets, USP can be found in 150 mg and 500 mg strengths in bottle rely sizes of 60 and 120, respectively.

Shares of Dr Reddy’s Laboratories have been buying and selling 0.98 per cent decrease at Rs 4,650 apiece on BSE.

This feed is robotically revealed through